iOnco
🔴

Cranberry

Vaccinium macrocarpon

Antioxidantmoderate evidence

Cranberry proanthocyanidins (PACs) and ursolic acid show anti-tumour activity against prostate, colon, breast, and ovarian cancers. PACs uniquely prevent bacterial adhesion to cells, important for UTI prevention in catheterised cancer patients. They also reduce cancer cell migration and invasion.

Medicinal Properties

AntioxidantAnti-tumourAnti-adhesionAnti-inflammatory
🎗️

Cancer Types Studied

ProstateColonBreastOvarian

Recommended Dosage

400–500 mg standardised cranberry extract daily, or 240 ml pure cranberry juice.

Preparations

Standardised Extract Capsules

400–500 mg extract (standardised to PACs) daily — much more concentrated than juice.

Pure Cranberry Juice (Unsweetened)

60–120 ml concentrated pure cranberry juice daily. Avoid sweetened versions.

NIH / PubMed Research

Links open on PubMed (National Library of Medicine). Research is ongoing — results may not reflect clinical use.

Cautions & Interactions

  • May interact with warfarin — affects INR
  • High in oxalates — caution with kidney stones
  • Sweetened cranberry products negate benefits — use unsweetened
  • May lower blood sugar

Informational only. Not medical advice. Consult your healthcare provider before use.